Quinoline derivatives as phosphodiesterase inhibitors

There are provided according to the invention novel compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R19, R20 and R34 are as described in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	BALDWIN IAN ROBERT,BARKER MICHAEL DAVID,DEAN ANTHONY WILLIAM,ELDRED COLIN DAVID,EVANS BRIAN,GOUGH SHARON LISA,GUNTRIP STEPHEN BARRY,HAMBLIN JULIE NICOLE,HOLMAN STUART,JONES PAUL,LINDVALL MIKA KRISTIAN, JANE,REDGRAVE ALISON JUDITH,ROBINSON JOHN EDWARD,WOODROW MICHAEL
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!